Involvement of JAK1, JAK2, and JAK3 in Stimulation of Functional Activity of Mesenchymal Progenitor Cells by Fibroblast Growth Factor

被引：0
|
作者：
G. N. Zyuz’kov
V. V. Zhdanov
E. V. Udut
L. A. Miroshnichenko
E. V. Simanina
T. Yu. Polyakova
L. A. Stavrova
V. V. Udut
M. Yu. Minakova
A. M. Dygai
机构：
[1] E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine,
[2] National Research Tomsk State University,undefined
来源：
Bulletin of Experimental Biology and Medicine | 2016年 / 162卷
关键词：
signal pathways; JAK; progenitor cells; regenerative medicine; fibroblast growth factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We studied the involvement of individual JAK kinases in the realization of the growth potential of mesenchymal precursors under the effect of fibroblast growth factor. The important role of JAK2 and JAK3 in determining the initial level of mitotic activity of progenitor cells and participation of JAK1 in this process under conditions of cytokine stimulation of progenitor cells were demonstrated. Specific inhibitors of these kinases reduced the yield of fibroblast CFU and the rate of their division. Moreover, blockade of JAK1, JAK2, and JAK3 under the effect of fibroblast growth factor was accompanied by an increase in the intensity of progenitor cell differentiation.
引用
收藏
页码：240 / 243
页数：3
相关论文
共 50 条
  • [21] Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor
    Quintas-Cardama, Alfonso
    Manshouri, Taghi
    Estrov, Zeev
    Harris, David
    Zhang, Ying
    Gaikwad, Amos
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 818 - 826
  • [22] CXCL12 signaling is independent of Jak2 and Jak3
    Moriguchi, M
    Hissong, BD
    Gadina, M
    Yamaoka, K
    Tiffany, HL
    Murphy, PM
    Candotti, F
    O'Shea, JJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) : 17408 - 17414
  • [23] Development of novel and potent inhibitors of JAK2: Structure activity relationship studies for optimiziation of JAK2 potency while minimizing JAK3 activity
    McPherson, Andrew
    Cao, Jianguo
    Chow, Chun
    Fine, Richard
    Hood, John
    Kang, Xinshan
    Klebansky, Boris
    Lohse, Dan
    Mak, Chi Ching
    Noronha, Glenn
    Pathak, Ved P.
    Renick, Joel
    Soll, Richard
    Zeng, Binqi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 779 - 779
  • [24] Pyrrolo[1,2-f]triazines as JAK2 inhibitors: Achieving potency and selectivity for JAK2 over JAK3
    Harikrishnan, Lalgudi S.
    Kamau, Muthoni G.
    Wan, Honghe
    Inghrim, Jennifer A.
    Zimmermann, Kurt
    Sang, Xiaopeng
    Mastalerz, Harold A.
    Johnson, Walter L.
    Zhang, Guifen
    Lombardo, Louis J.
    Poss, Michael A.
    Trainor, George L.
    Tokarski, John S.
    Lorenzi, Matthew V.
    You, Dan
    Gottardis, Marco M.
    Baldwin, Kathy F.
    Lippy, Jonathan
    Nirschl, David S.
    Qiu, Ruhui
    Miller, Arthur V.
    Khan, Javed
    Sack, John S.
    Purandare, Ashok V.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1425 - 1428
  • [25] Prevention of Islet Inflammatory Stress with JAK1/JAK2 Inhibitors
    Watson, Eleanor
    Waibel, Michaela
    Trivedi, Prerak
    Pappas, Evan
    Fynch, Stacey
    Sutherland, Robyn
    Kay, Thomas
    Thomas, Helen
    TRANSPLANTATION, 2018, 102 : S370 - S370
  • [26] INTERACTION OF JAK1 AND JAK3 TYROSINE KINASES WITH THE IL2 RECEPTOR COMPLEX
    KIRKEN, RA
    RUI, H
    MALABARBA, MG
    KAWAMURA, M
    OSHEA, JJ
    FARRAR, WL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 38 - 38
  • [27] Selective Downregulation of JAK2 and JAK3 by an ATP-Competitive pan-JAK Inhibitor
    Field, S. Denise
    Arkin, Jacob
    Li, Jing
    Jones, Lyn H.
    ACS CHEMICAL BIOLOGY, 2017, 12 (05) : 1183 - 1187
  • [28] Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
    Dai, Z.
    Loesch, E.
    Chen, J. C.
    Wang, E.
    Lee, E.
    Christiano, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S119 - S119
  • [29] Molecular Dynamics Simulation of the Selectivity of Fedratinib Complex with JAK2/JAK3
    Liu Haichun
    Lu Shuai
    Zhang Yanmin
    Zhou Weineng
    Yin Lingfeng
    Zhu Lu
    Zhao Junnan
    Lu Tao
    Chen Yadong
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2018, 39 (07): : 1540 - 1548
  • [30] The growth hormone receptor associates with Jak1, Jak2 and Tyk2 in human liver
    Hellgren, G
    Jansson, JO
    Carlsson, LMS
    Carlsson, B
    GROWTH HORMONE & IGF RESEARCH, 1999, 9 (03) : 212 - 218
12345